Physician

Francisco Andres Folgar, M.D.

According to 2025 Medicare claims, Francisco Folgar, M.D. (NPI: 1801060454) practices ophthalmology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is CAROLINA EYECARE PHYSICIANS LLC (NPI: 1659421238; TIN: 58-2353352) and primary practice location at 29464-3138.

Folgar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,579 traditional Medicare patients, billed 79,494 HCPCS/CPT codes, and received $3,104,133 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 813 prescription claims across 231 beneficiaries totaling $38,138 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 25 records totaling $26,113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $254,218 to $3,104,133. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2015 Medicare payment: $254,218 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,203,365 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,108,910 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,313,138 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,526,499 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,896,668 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,122,842 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,955,197 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,363,534 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,104,133 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154331,546$254,218
20161,5668,589$1,203,365
20171,5139,805$1,108,910
20181,82411,105$1,313,138
20191,93412,744$1,526,499
20201,81813,054$1,896,668
20211,85413,427$2,122,842
20221,61612,691$1,955,197
20231,56223,340$2,363,534
20241,57979,494$3,104,133

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$41K$82K2015 Drug cost: $18,386 (USD; Tot_Drug_Cst)2016 Drug cost: $39,564 (USD; Tot_Drug_Cst)2017 Drug cost: $42,359 (USD; Tot_Drug_Cst)2018 Drug cost: $47,604 (USD; Tot_Drug_Cst)2019 Drug cost: $65,790 (USD; Tot_Drug_Cst)2020 Drug cost: $82,092 (USD; Tot_Drug_Cst)2021 Drug cost: $73,025 (USD; Tot_Drug_Cst)2022 Drug cost: $55,707 (USD; Tot_Drug_Cst)2023 Drug cost: $50,080 (USD; Tot_Drug_Cst)2024 Drug cost: $38,138 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201589234$18,386
2016170545$39,564
2017149692$42,359
2018151611$47,604
2019179784$65,790
2020195895$82,092
2021203828$73,025
2022184762$55,707
2023204789$50,080
2024231813$38,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1732,042$657
67028Injection of drug into eye3702,019$87
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,5142,516$83
92134Imaging of retina1,3093,352$27
92250Photography of the retina393455$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1968,228$10,216
Lotemax SmLoteprednol Etabonate18500$4,581
Atropine SulfateAtropine Sulfate1232,493$3,206
Brimonidine TartrateBrimonidine Tartrate523,072$1,532
Ketorolac TromethamineKetorolac Tromethamine361,634$1,527

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$8,198Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$17,915Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Francisco Andres Folgar, M.D.?

Tedicare shows public-source Medicare data for Francisco Andres Folgar, M.D. (NPI 1801060454), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Francisco Andres Folgar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Francisco Andres Folgar, M.D.?

Francisco Andres Folgar, M.D. is linked to CAROLINA EYECARE PHYSICIANS LLC (billing NPI 1659421238) in the available physician profile data.

Does Francisco Andres Folgar, M.D. have Open Payments data?

Francisco Andres Folgar, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.